A novel role for interferon regulatory factor 1 (IRF1) in regulation of bone metabolism

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 8, 2014, Pages 1588-1598

  Salem, Sandra ^a   Gao, Chan ^a,b   Li, Ailian ^b   Wang, Huifen ^b   Nguyen Yamamoto, Loan ^a   Goltzman, David ^a   Henderson, Janet E ^a,b   Gros, Philippe ^a  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Bone development; Bone resorption; Knockout mouse; Mesenchymal cell differentiation; Osteoclast differentiation

Indexed keywords

INTERFERON REGULATORY FACTOR 1; IRF1 PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL; BONE; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE AND BONES; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; INTERFERON REGULATORY FACTOR-1; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84912531058     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12327     Document Type: Article

References (51)

1. Barnes B, Lubyova B, Pitha PM. On the role of IRF in host defense. J Interferon Cytokine Res. 2002; 22: 59-71.
2. Harada H, Fujita T, Miyamoto M, et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 1989; 58: 729-39.
3. Penninger JM, Sirard C, Mittrucker HW, et al. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity. 1997; 7: 243-54.
4. Taki S, Sato T, Ogasawara K, et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 1997; 6: 673-9.
5. Gabriele L, Fragale A, Borghi P, et al. IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. J Leukoc Biol. 2006; 80: 1500-11.
6. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491: 119-24.
7. Tada Y, Ho A, Matsuyama T, et al. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med. 1997; 185: 231-8.
8. Tanaka N, Ishihara M, Kitagawa M, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 1994; 77: 829-39.
9. Willman CL, Sever CE, Pallavicini MG, et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science. 1993; 259: 968-71.
10. Eisenbeis CF, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 1995; 9: 1377-87.
11. Meraro D, Hashmueli S, Koren B, et al. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J Immunol. 1999; 163: 6468-78.
12. Tamura T, Ozato K. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J Interferon Cytokine Res. 2002; 22: 145-52.
13. Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendriticcell immunodeficiency. N Engl J Med. 2011; 365: 127-38.
14. Xiong H, Zhu C, Li H, et al. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFNgamma-induced iNOS gene expression. J Biol Chem. 2003; 278: 2271-7.
15. Eklund EA, Jalava A, Kakar R. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J Biol Chem. 1998; 273: 13957-65.
16. Liu J, Guan X, Tamura T, et al. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem. 2004; 279: 55609-17.
17. Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002; 109: 1405-15.
18. Lam J, Takeshita S, Barker JE, et al. TNFalpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000; 106: 1481-8.
19. Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008; 29: 403-40.
20. Amcheslavsky A, Bar-Shavit Z. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J Cell Physiol. 2006; 207: 244-50.
21. Horwood NJ, Udagawa N, Elliott J, et al. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest. 1998; 101: 595-603.
22. Wintges K, Beil FT, Albers J, et al. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5). J Bone Miner Res. 2013; 28: 2070-80.
23. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010; 42: 1118-25.
24. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-62.
25. Elding H, Lau W, Swallow DM, et al. Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. Am J Hum Genet. 2011; 89: 798-805.
26. Ali T, Lam D, Bronze MS, et al. Osteoporosis in inflammatory bowel disease. Am J Med. 2009; 122: 599-604.
27. Lin CL, Moniz C, Chambers TJ, et al. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology. 1996; 111: 1263-71.
28. Zhao B, Takami M, Yamada A, et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med. 2009; 15: 1066-71.
29. Glatt V, Canalis E, Stadmeyer L, et al. Agerelated changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007; 22: 1197-207.
30. Valverde-Franco G, Liu H, Davidson D, et al. Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum Mol Genet. 2004; 13: 271-84.
31. Fleit HB, Rabinovitch M. Interferon induction in marrow-derived macrophages: regulation by L cell conditioned medium. J Cell Physiol. 1981; 108: 347-52.
32. Marks SC Jr, Popoff SN. Bone cell biology: the regulation of development, structure, and function in the skeleton. Am J Anat. 1988; 183: 1-44.
33. Turner CH, Hsieh YF, Muller R, et al. Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res. 2000; 15: 1126-31.
34. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003; 423: 349-55.
35. Lynch MP, Capparelli C, Stein JL, et al. Apoptosis during bone-like tissue development in vitro. J Cell Biochem. 1998; 68: 31- 49.
36. Fujikawa Y, Quinn JM, Sabokbar A, et al. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology. 1996; 137: 4058-60.
37. Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 1994; 263: 1612-5.
38. Lees RL, Sabharwal VK, Heersche JN. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films. Bone. 2001; 28: 187-94.
39. Doody KM, Bussieres-Marmen S, Li A, et al. T cell protein tyrosine phosphatase deficiency results in spontaneous synovitis and subchondral bone resorption in mice. Arthritis Rheum. 2012; 64: 752-61.
40. Tsuboi H, Matsui Y, Hayashida K, et al. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis. 2003; 62: 196-203.
41. Lohoff M, Ferrick D, Mittrucker HW, et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 1997; 6: 681-9.
42. Chatterjee-Kishore M, Wright KL, Ting JP, et al. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 2000; 19: 4111-22.
43. Ramsauer K, Farlik M, Zupkovitz G, et al. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci USA. 2007; 104: 2849-54.
44. Kim S, Koga T, Isobe M, et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 2003; 17: 1979- 91.
45. Stark GR, Kerr IM, Williams BR, et al. How cells respond to interferons. Annu Rev Biochem. 1998; 67: 227-64.
46. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999; 402: 304-9.
47. Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000; 408: 600-5.
48. Taniguchi T, Ogasawara K, Takaoka A, et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001; 19: 623-55.
49. Takayanagi H, Kim S, Matsuo K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature. 2002; 416: 744-9.
50. Hsu YH, Zillikens MC, Wilson SG, et al. An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet. 2010; 6: e1000977.
51. Rivadeneira F, Styrkarsdottir U, Estrada K, et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41: 1199-206.